We are live on ! Find out more
AVNS icon

Avanos Medical
AVNS

467 hedge funds and large institutions have $1.6B invested in Avanos Medical in 2014 Q4 according to their latest regulatory filings, with 467 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

18% less call options, than puts

Call options by funds: $7.47M | Put options by funds: $9.08M

Holders
467
Holders Change
+467
Holders Change %
–
% of All Funds
12.46%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.05%
New
467
Increased
–
Reduced
–
Closed
–
Calls
$7.47M
Puts
$9.08M
Net Calls
-$1.61M
Net Calls Change
-$1.61M

Top Buyers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$125M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$112M
3
GC
Greenlight Capital
New York
+$92.5M
4
RP
RR Partners
New York
+$74.7M
5
BIT
BlackRock Institutional Trust
California
+$74.3M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$145M +$125M +3,189,935 New
Vanguard Group
2
Vanguard Group
Pennsylvania
$130M +$112M +2,859,903 New
GC
3
Greenlight Capital
New York
$107M +$92.5M +2,353,181 New
RP
4
RR Partners
New York
$86.4M +$74.7M +1,900,600 New
BIT
5
BlackRock Institutional Trust
California
$86M +$74.3M +1,891,913 New
State Street
6
State Street
Massachusetts
$61.8M +$53.4M +1,358,352 New
BFA
7
BlackRock Fund Advisors
California
$54.9M +$47.4M +1,207,116 New
HM
8
HealthCor Management
New York
$43.2M +$37.4M +950,800 New
Acadian Asset Management
9
Acadian Asset Management
Massachusetts
$31.6M +$27.3M +693,907 New
ClearBridge Investments
10
ClearBridge Investments
New York
$30.1M +$26M +662,752 New
Norges Bank
11
Norges Bank
Norway
$28.5M +$24.6M +627,274 New
Arrowstreet Capital
12
Arrowstreet Capital
Massachusetts
$27.3M +$23.6M +601,273 New
Bank of America
13
Bank of America
North Carolina
$25.6M +$22.1M +562,452 New
Bank of New York Mellon
14
Bank of New York Mellon
New York
$24.5M +$21.1M +537,858 New
Morgan Stanley
15
Morgan Stanley
New York
$22.9M +$19.8M +504,429 New
Northern Trust
16
Northern Trust
Illinois
$22.2M +$19.2M +487,469 New
ACM
17
Americafirst Capital Management
California
$21.1M +$18.2K +463 New
BM
18
Bridger Management
New York
$18.8M +$16.3M +413,662 New
BG
19
BlackRock Group
United Kingdom
$17.9M +$15.5M +394,229 New
Capital World Investors
20
Capital World Investors
California
$17.2M +$14.8M +377,500 New
HCM
21
Hodges Capital Management
Texas
$16.9M +$14.6M +372,073 New
RFC
22
Russell Frank Company
Washington
$16.7M +$14.7M +373,699 New
Tudor Investment Corp
23
Tudor Investment Corp
Connecticut
$15M +$12.9M +329,108 New
GAM
24
Gotham Asset Management
New York
$14.6M +$12.6M +320,792 New
MNA
25
Manning & Napier Advisors
New York
$14.6M +$12.6M +320,261 New
1
2 3 4 5

AVNS Hedge Fund Activity: Q4 2014 in Review

467 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q4 2014, worth a combined $1.6B.

Buyers outnumbered sellers: 467 funds opened new AVNS positions and 0 closed out — a net gain of 467 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was T. Rowe Price Associates, opening a new position worth an estimated $125M.

  • 467 institutional investors held Avanos Medical (AVNS) as of Q4 2014, up from 0 in Q3 2014.
  • Funds reported $1.6B of Avanos Medical stock for Q4 2014.
  • 467 funds opened new Avanos Medical positions in Q4 2014 and 0 closed out, a net change of +467 holders.
  • The largest Avanos Medical buyer in Q4 2014 was T. Rowe Price Associates, an estimated $125M added.

Based on aggregated 13F filings for Q4 2014.